TactiCath Post Market Approval Study
Brief Description Of Study
The purpose of the research study is to obtain additional information safety and effectiveness of an FDA approved catheter when used to treat patients with Paroxysmal atrial fibrillation.
Detailed Study Description
The purpose of the study is to provide data and safety for the Food and Drug administration (FDA). The study is designed for patients with paroxysmal atrial fibrillation. Participants will only be enrolled if at the time of consent present with paroxysmal atrial fibrillation and meet criteria for an ablation procedure. The study is seeking participants willing to be followed for a period of 5 years